Hepatology
News
Drugs
Xagena Medicine
Xagena.net
Chronic hepatitis B, Telbivudine achieves primary endpoint in GLOBE trial
Chronic hepatitis B, Pegasys as a first-line therapy
Therapy may not be necessary for autoimmune hepatitis with no symptoms
Developed comprehensive protocol for liver transplants in children with maple syrup urine disease
Transmission of hepatitis C among family members
How HCV evades the body’s immune system during infection
Hepatitis C protease inhibitor, VX-950, reduces viral levels
Nonalcoholic steatohepatitis, is Pentoxifylline effective ?
Genes linked to treatment resistance in children with leukaemia
Obstructive sleep apnea may be a risk factor for liver damage
FDA approves Pegasys for the treatment of chronic hepatitis B
Chronic hepatitis C, Peginterferon alfa-2b plus Ribavirin in children and adolescents
Chronic hepatitis B, FDA approves Entecavir
European Union, Pegasys approved for the treatment of chronic hepatitis B
Next Pages
1
[
2
]
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions